Sidhom Youssef, Damak Mariem, Riahi Anis, Hizem Yosr, Mrissa Ridha, Mhiri Chokri, Gouider Riadh
Department of Neurology, Razi Hospital, Mannouba, Tunisia.
Department of Neurology, Habib Bourguiba Hospital, Sfax, Tunisia.
J Neurol Sci. 2014 Aug 15;343(1-2):110-4. doi: 10.1016/j.jns.2014.05.049. Epub 2014 Jun 2.
Few epidemiological data are available on multiple sclerosis (MS) patients in North Africa (NA). Studies of immigrants from NA showed a more aggressive course compared to European patients.
The aim of this study is to describe clinical and long term course characteristics of MS in Tunisia and to compare it to European cohorts.
A total of 437 MS patients from three hospital based cohorts in Tunisia and having prospective follow up between 2010 and 2012 were analyzed. We considered as endpoints the time to reach EDSS scores of 3, 4 and 6 in the different clinical forms of MS and the beginning of a secondary progressive (SP) phase.
Sex ratio was 2.34. Mean age of onset was 30.3 years. The course was relapsing-remitting (RR) in 91% of patients and primary progressive (PP) in 9%. The most frequent isolated onset symptoms were respectively motor (28%), optic neuritis (20%) and sensory (16%) dysfunction. Median time to SP onset was 19.1 years. Median times from onset of multiple sclerosis to assignment of a score of 3, 4 and 6 were 8, 10.7 and 15 years respectively. Benign form of MS represented 31.5%. Median interval from the onset of the disease to EDSS score of 3, 4 and 6 was shorter in PP-MS than in RR-MS. However, there was no difference between these two groups for the median time from the assignment of EDSS 4 to the assignment EDSS 6.
Our study shows that Tunisian MS patients have a quite similar clinical feature to European patients. Still, larger MS multicenter cohort studies in NA with longer follow-up duration could clearly respond to the issue.
北非(NA)多发性硬化症(MS)患者的流行病学数据较少。对来自北非移民的研究表明,与欧洲患者相比,其病程更具侵袭性。
本研究旨在描述突尼斯MS患者的临床和长期病程特征,并与欧洲队列进行比较。
对来自突尼斯三个基于医院的队列、在2010年至2012年期间进行前瞻性随访的437例MS患者进行分析。我们将MS不同临床形式中达到扩展残疾状态量表(EDSS)评分3、4和6的时间以及继发进展型(SP)阶段的开始视为终点。
性别比为2.34。平均发病年龄为30.3岁。91%的患者病程为复发缓解型(RR),9%为原发进展型(PP)。最常见的孤立起病症状分别为运动功能障碍(28%)、视神经炎(20%)和感觉功能障碍(16%)。SP发病的中位时间为19.1年。从多发性硬化症发病到获得3分、4分和6分的中位时间分别为8年、10.7年和15年。MS的良性形式占31.5%。PP-MS从疾病发作到EDSS评分为3、4和6的中位间隔时间比RR-MS短。然而,这两组从EDSS评分为4到评分为6的中位时间没有差异。
我们的研究表明,突尼斯MS患者的临床特征与欧洲患者非常相似。尽管如此,在北非进行更大规模、随访时间更长的MS多中心队列研究可以更清楚地回答这个问题。